EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
published in: Annals of the Rheumatic Diseases
date of publication: 2020-04-23
main subject: immunotherapy
Cites articles
There is nothing here
Article - wd:Q93194405